Aslan Fred

Chief Executive Officer

Aslan Fred has filed 12 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.

On the most recent filing, Aslan Fred is listed as Chief Executive Officer at Artiva Biotherapeutics, Inc. Inside the rolling window, Aslan Fred reported no open-market purchases and 7 open-market sales totaling $1.8M in ARTV. The largest disclosed transaction in the window is a sale of 61,888 ARTV shares on Sep 3, 2026, worth $690K.

Companies traded

Other insiders at ARTV

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ARTVSale$169KOct 7SEC ↗
ARTVSale$422KOct 6SEC ↗
ARTVSale$256KSep 9SEC ↗
ARTVSale$690KSep 4SEC ↗
ARTVSale$244KMay 20SEC ↗
ARTVSale$19KDec 15SEC ↗
ARTVSale$22KNov 17SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 17, 2025ARTVSale$153K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Aslan Fred made?

Aslan Fred has filed 12 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does Aslan Fred trade?

Aslan Fred has filed SEC Form 4 disclosures for 1 company, including ARTV.

When was Aslan Fred's most recent SEC Form 4 filing?

Aslan Fred's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.

What is Aslan Fred's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Aslan Fred is listed as Chief Executive Officer.

What is Aslan Fred's total buy and sell value in the current window?

Inside the rolling retention window, Aslan Fred bought $0 and sold $1.8M based on SEC Form 4 filings.

What was Aslan Fred's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 61,888 ARTV shares on 2026-09-03, worth $690K, per SEC Form 4 filings.